Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded
- Contract number
- SPE2DB25FDJ14
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,625
Award facts
- Contract value 100% obligated
- $39,625.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $39,625.20 to DMS Pharmaceutical Group Inc. for the supply of EYLEA HD 8 mg/0.07 mL vials. EYLEA is a prescription ophthalmic medication used to treat age-related macular degeneration and other retinal conditions. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order with an ultimate completion date of May 16, 2025. This award was made without a set-aside designation, allowing the company to compete on the open market despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that authorizes firm fixed-price orders for pharmaceutical products supporting military health facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of federal contract awards covering an extensive range of medications, biologics, and medical consumables. The company's positioning enables direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FDJ14?
SPE2DB25FDJ14 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 25, 2025.
How much is contract SPE2DB25FDJ14 worth?
The government has obligated $39,625 on SPE2DB25FDJ14.
Is contract SPE2DB25FDJ14 an order under another contract?
Yes. SPE2DB25FDJ14 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDJ14 competed?
The extent of competition for SPE2DB25FDJ14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award